Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Mutant KRAS Enhances Stress Granules and Resistance to Proteasome Inhibition Via 15-d-PGJ2 in Multiple Myeloma

Ya-Wei Qiang, MD PhD, Shiqiao Ye, PhD BSc, MSc, Yu Chen, Joshua Epstein, DSc, Faith E. Davies, MD, Gareth Morgan, MD PhD, Brian A Walker, PhD, Frits van Rhee, MD PhD

Blood (2019) 134 (Supplement_1): 4383.

https://doi.org/10.1182/blood-2019-130493

Published: 2019

Journal Articles

Mutant KRAS and Brafs Upregulate Stress Granules and Mediate Drug Resistance, Which Can be Modulated By Cox2 Inhibition in Multiple Myeloma

Ya-Wei Qiang, MD PhD, Shiqiao Ye, PhD BSc, MSc, Yu Chen, Joshua Epstein, DSc, Brian A Walker, PhD, Frits van Rhee, MD PhD, Gareth Morgan, MD, Faith E. Davies, MD

Blood (2018) 132 (Supplement 1): 3166.

https://doi.org/10.1182/blood-2018-99-117459

Published: 2018

Journal Articles

Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia

Areej El-Jawahri, MD, Gregory A. Abel, MD, Joseph Greer, PhD, Amir T. Fathi, MD MD BS, David P. Steensma, MD, Thomas W. LeBlanc, MD MA, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Julia Foster, ANP, Andrew Mark Brunner, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD

Blood (2017) 130 (Supplement 1): 349.

https://doi.org/10.1182/blood.V130.Suppl_1.349.349

Published: 2017

Journal Articles

What Do Transplant Physicians Think about Palliative Care? A National Survey Study

Areej El-Jawahri, MD, Thomas W. LeBlanc, MD MA, Linda J. Burns, MD, Ellen Denzen, MS, Christa Lea Meyer, MS, Lih-Wen Mau, PhD MPH, Eric J. Roeland, MD, William A. Wood, MD MPH, Effie Petersdorf, MD

Blood (2017) 130 (Supplement 1): 3388.

https://doi.org/10.1182/blood.V130.Suppl_1.3388.3388

Published: 2017

Journal Articles

Multiple Myeloma Symptom Burden, Perceived Control, and Quality of Life: Findings from the Cancer Experience Registry

Alexandra K Zaleta, PhD, Melissa F. Miller, PhD MPH, Shauna McManus, BS, Jamese Johnson, MPH, Clare Karten, MS, Thomas W. LeBlanc, MD MA, Craig E. Cole, MD, Joanne S. Buzaglo, PhD

Blood (2017) 130 (Supplement 1): 5629.

https://doi.org/10.1182/blood.V130.Suppl_1.5629.5629

Published: 2017

Journal Articles

Patient-Reported Distress in Hodgkin Lymphoma Patients on Active Therapy Vs. Long-Term Survivors

Jesse D Troy, PhD MPH, Susan C. Locke, PhD, Mary Ruth Pupa, BSN, Joseph Feliciano, PharmD, Akshara Richhariya, PhD, Thomas W. LeBlanc, MD MA

Blood (2017) 130 (Supplement 1): 2173.

https://doi.org/10.1182/blood.V130.Suppl_1.2173.2173

Published: 2017

Journal Articles

Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia

Anthony D. Sung, MD, Carlos M. de Castro, MD, Thomas W. LeBlanc, MD MA, Gwynn D. Long, MD, Donna B. Adams, NP, Danielle M. Brander, MD, Sandeep Dave, MD, Louis F. Diehl, MD, Phuong Linh Doan, MD, Therese Hennig, PA, Yubin Kang, MD, Matthew S. McKinney, MD, Lindsay A.M Rein, MD, Dorothy A. Sipkins, MD, Yiping Yang, MD PhD, Nelson J. Chao, MDM.B.A, David A. Rizzieri, MD

Blood (2017) 130 (Supplement 1): 3853.

https://doi.org/10.1182/blood.V130.Suppl_1.3853.3853

Published: 2017

Journal Articles

Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia

Adam J Olszewski, MD, Pamela C Egan, MD, Thomas W. LeBlanc, MD MA

Blood (2017) 130 (Supplement 1): 277.

https://doi.org/10.1182/blood.V130.Suppl_1.277.277

Published: 2017

Journal Articles

Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Real-World US Practices

Thomas W. LeBlanc, MD MA, Azah Borham, PharmD, Yun Su, MD MPH, MS, Karin Chun Hayes, Russel Fielding, Michael Benigno, MA, Joseph C. Cappelleri, PhD MPH, MS

Blood (2017) 130 (Supplement 1): 1328.

https://doi.org/10.1182/blood.V130.Suppl_1.1328.1328

Published: 2017

Journal Articles

Ponatinib Exerts Multiple Effects on Vascular Endothelial Cells: Possible Mechanisms and Explanations for the Adverse Vascular Events Seen in CML Patients Treated with Ponatinib

Emir Hadzijusufovic, DVM, Rudolf Kirchmair, MD, Markus Theurl, MD, Susanne Gamperl, MSc, Daniela Lener, Clemens Gutmann, Ursula Stanzl, Andrijana Kirsch, MD, Sasa Frank, PhD, Peter Valent, MD

Blood (2016) 128 (22): 1883.

https://doi.org/10.1182/blood.V128.22.1883.1883

Published: 2016

Journal Articles

High Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) Transcriptional Activity Reduces Active Influx of Imatinib and Kinase Inhibition in CML Cells

Jueqiong WANG, PhD, Chung Hoow Kok, PhD, Tamara M Leclercq, PhD, Verity A Saunders, BSc (Hons), Richard J D'Andrea, PhD, Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Deborah L White, PhD FFSc (RCPA)

Blood (2015) 126 (23): 2770.

https://doi.org/10.1182/blood.V126.23.2770.2770

Published: 2015

Journal Articles

Diclofenac Induces Apoptosis and Suppresses Diffuse Large B-Cell Lymphoma Proliferation Independent of P53 Status

Hesham Hassan, MSc, Michelle Varney, M.S., Bhavana J Dave, PhD, Rakesh K Singh, PhD

Blood (2014) 124 (21): 5485.

https://doi.org/10.1182/blood.V124.21.5485.5485

Published: 2014

Journal Articles

Role Of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Its Ligands In The Regulation Of Functional OCT-1 Activity In CML Cells

Jueqiong Wang, PhD, Chung Hoow Kok, PhD, Richard J. D'Andrea, PhD, Timothy P. Hughes, MD, MBBS, Deborah L. White, PhD, FFSc(RCPA)

Blood (2013) 122 (21): 1470.

https://doi.org/10.1182/blood.V122.21.1470.1470

Published: 2013

Journal Articles

Non-Steroidal Anti-Inflammatory Drugs and Imatinib; Drug Interactions That May Impact Efficacy,

Jueqiong Wang, MMed, Timothy P Hughes, MD, MBBS, Chung Hoow Kok, PhD, Verity A Saunders, BScHons, Amity Frede, BScHons, Kelvin GrootObbink, BScHons, Michael Philip Osborn, MBBS, Andrew A Somogyi, PhD, Richard J D'Andrea, PhD, Deborah L. White, PhD. FFSc(RCPA)

Blood (2011) 118 (21): 3501.

https://doi.org/10.1182/blood.V118.21.3501.3501

Published: 2011

Journal Articles

Ap-1 Family Members C-Jun, JunB and Fra-2 Mediate Apoptosis and Differentiation in AML through Activation of GADD45á and ADFP Following Non-Steroidal Anti-Inflammatory Drug Treatment.

Akos Czibere, MD, PhD, Raminder Singh, PhD, Ingmar Bruns, MD, PhD, Luiz Fernando Zerbini, PhD, Rainer Haas

Blood (2008) 112 (11): 1196.

https://doi.org/10.1182/blood.V112.11.1196.1196

Published: 2008

Journal Articles

No Effect of Etodolac, a COX Inhibitor, on Platelet Function in Healthy Volunteers.

Wolfgang C. Korte, MD, Giuseppe Plebani, MD

Blood (2007) 110 (11): 2098.

https://doi.org/10.1182/blood.V110.11.2098.2098

Published: 2007

NARROW

Mutant KRAS Enhances Stress Granules and Resistance to Proteasome Inhibition Via 15-d-PGJ2 in Multiple Myeloma

Mutant KRAS and Brafs Upregulate Stress Granules and Mediate Drug Resistance, Which Can be Modulated By Cox2 Inhibition in Multiple Myeloma

Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia

What Do Transplant Physicians Think about Palliative Care? A National Survey Study

Multiple Myeloma Symptom Burden, Perceived Control, and Quality of Life: Findings from the Cancer Experience Registry

Patient-Reported Distress in Hodgkin Lymphoma Patients on Active Therapy Vs. Long-Term Survivors

Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia

Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia

Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Real-World US Practices

Ponatinib Exerts Multiple Effects on Vascular Endothelial Cells: Possible Mechanisms and Explanations for the Adverse Vascular Events Seen in CML Patients Treated with Ponatinib

High Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) Transcriptional Activity Reduces Active Influx of Imatinib and Kinase Inhibition in CML Cells

Diclofenac Induces Apoptosis and Suppresses Diffuse Large B-Cell Lymphoma Proliferation Independent of P53 Status

Role Of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Its Ligands In The Regulation Of Functional OCT-1 Activity In CML Cells

Non-Steroidal Anti-Inflammatory Drugs and Imatinib; Drug Interactions That May Impact Efficacy,

Ap-1 Family Members C-Jun, JunB and Fra-2 Mediate Apoptosis and Differentiation in AML through Activation of GADD45á and ADFP Following Non-Steroidal Anti-Inflammatory Drug Treatment.

No Effect of Etodolac, a COX Inhibitor, on Platelet Function in Healthy Volunteers.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only